Study of Infantile Lower Limb Malformations and Deformities (REMEDIA-I)

December 19, 2025 updated by: Istituto Ortopedico Rizzoli

Observational Retrospective and Prospective Study of Infantile Lower Limb Malformations and Deformities

The skeletal defects of the lower limbs in pediatric age encompass various congenital and acquired conditions that alter bone structure. These alterations can be symmetrical or asymmetrical, with potential consequences such as deformities, short stature, and disability. These condictions may impact not only on the physical and the mental function of the children, but also on their family context.

Management often requires a multidisciplinary approach for early diagnosis and treatment. Deformities are heterogeneous and necessitate a personalized therapeutic plan.

Currently, in pediatric orthopedic surgery there is a lack of an instrument capable of evaluating all these aspects.

The advancement of computer-assisted surgery and artificial intelligence could improve treatment customization and involve patients and families in therapeutic decision-making to prevent complications. This study aims to provide support for clinical practice to promote a systematic, comprehensive, and sequential evaluation of lower limb deformities in developmental age, from which epidemiological data and evidence on treatment approaches used in major referral centers can be extrapolated.

Study Overview

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bologna, Italy, 40136
        • Recruiting
        • IRCCS Istituto Ortopedico Rizzoli
        • Contact:
      • Genova, Italy
      • Milan, Italy
      • Pavia, Italy
        • Not yet recruiting
        • Policlinico San Matteo
        • Contact:
          • Gianluigi Pasta, MD
      • Roma, Italy
        • Not yet recruiting
        • Istituto Nazionale Tumori Regina Elena
        • Contact:
      • Roma, Italy
      • Rozzano, Italy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with congenital or acquired deformity of one or both lower limb diagnosed before skeletal maturity.

Description

Inclusion Criteria:

  • Age < 18 years at the time of initial orthopedic evaluation
  • Diagnosis of congenital or acquired musculoskeletal deformity to one or both lower limbs
  • Presence of informed consent to participate in the study

Exclusion Criteria:

  • Refuse to participate in the study by the patient or parent/legal guardian
  • Patients with mild paramorphisms not associated with functional limitations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children and adolescent with lower limb deformities
Patients are provided with physiotherapy support and the provision of prostheses with the goal of ensuring as much walking functionality as possible.
Correction of the deformity is pursued by one or more surgical procedures with the timing and the techniques (growth modulation, acute correction, gradual correction, soft tissues procedures, combined techniques) chosen according to the surgeon's preference to achieve the maximum possible walking functionality without orthopedic aids.
Limb surgery, whether or not associated with realignment or soft-tissue surgery, is performed, aimed at providing the maximum possible walking function through a prosthesis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pediatric Outcomes Data Collection Instrument
Time Frame: At baseline (day 0)
The scores, reported by the child and the caregiver, on the items of the questionnaire, which includes upper extremity (UE), transfer/basic mobility (TBM), happiness (Hap), sports/physical function (SPF), pain/comfort (PC)
At baseline (day 0)
Pediatric Outcomes Data Collection Instrument
Time Frame: After 1 year
The scores, reported by the child and the caregiver, on the items of the questionnaire, which includes upper extremity (UE), transfer/basic mobility (TBM), happiness (Hap), sports/physical function (SPF), pain/comfort (PC)
After 1 year
Clinical examination with complete assessment of lower limbs
Time Frame: At baseline (day 0)
Full assessment of parameters about lower limb alignment
At baseline (day 0)
Clinical examination with complete assessment of lower limbs
Time Frame: After 1 year
Full assessment of parameters about lower limb alignment
After 1 year
Mental Health
Time Frame: At baseline (day 0)
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health.
At baseline (day 0)
Mental Health
Time Frame: After 1 year
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health.
After 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pierfrancesco Costici, MD, Ospedale Pediatrico Bambin Gesù
  • Principal Investigator: Giorgio Marrè Brunenghi, MD, Istituto Giannina Gaslini
  • Principal Investigator: Fabio Verdoni, MD, Galeazzi Orthopedic Institute
  • Principal Investigator: Roberto Biagini, MD, Istituto Nazionale Tumori Regina Elena
  • Principal Investigator: Gianluigi Pasta, MD, Policlinico San Matteo
  • Principal Investigator: Tommaso Bonanzinga, MD, Istituto Clinico Humanitas

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 31, 2024

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2029

Study Registration Dates

First Submitted

May 6, 2024

First Submitted That Met QC Criteria

July 22, 2024

First Posted (Actual)

July 25, 2024

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deformity of Limb

Clinical Trials on Conservative treatment

Subscribe